Vitamin D3 in Pediatric SLE - Full Text View - ClinicalTrials.gov

Vitamin D3 in Pediatric SLE - Full Text View - ClinicalTrials.gov

NIAID Clinical Trial Studies Vitamin D3 in Pediatric Systemic Lupus Erythematosus

An NIAID-sponsored clinical trial is evaluating how vitamin D supplementation affects the immune function, blood sugar levels, and bone metabolism of children and adolescents who have systemic lupus erythematosus (SLE). People with SLE ages 5 to 20 may be eligible to participate in this study, which is being conducted at research institutions across the United States.

Did you know?

• The causes of SLE are unknown, but are believed to be linked to genetic, environmental, and hormonal factors.
• Females are affected by SLE far more than males.
• SLE disproportionately affects ethnic minority populations.

Read more about the clinical research study of vitamin D3 in pediatric SLE (ClinicalTrials.gov identifier NCT01709474).